medneo UK Limited (and associated subsidiaries: medneo Diagnostics UK Ltd and medneo Logistics UK Ltd)
medneo UK Limited and its subsidiary companies (“the Company”) is committed to ethical, transparent, and responsible business practices. We take a zero-tolerance approach to modern slavery and human trafficking in all forms. This statement outlines the actions we have taken and continue to take to ensure that modern slavery and human trafficking do not occur within our operations or supply chains. This statement is made pursuant to section 54(1) of the Modern Slavery Act 2015 and relates to the financial year ending 31st December 2024.
The Company provides advanced diagnostic imaging services to healthcare providers across the UK. As part of our operations, we work with a global network of suppliers and partners. Our organisational structure is designed to mitigate the risk of modern slavery by ensuring that ethical labour practices are embedded in both our supply chain and operational activities.
To address modern slavery risks, our organisational structure includes:
Our policies underpin our commitment to tackling modern slavery, including:
The Company implements rigorous due diligence processes in our procurement activities to minimise the risk of modern slavery in our supply chain. These processes include:
The Company monitor the effectiveness of its modern slavery prevention efforts through several key performance indicators (KPIs), which are reviewed annually. These include:
Training plays a crucial role in the Company’s strategy to combat modern slavery. The Company provide mandatory modern slavery training for all managers and those employees who are involved with direct communication when contracting suppliers.
The training includes:
The Company encourages its suppliers to provide similar training for their employees, further promoting ethical practices throughout the supply chain.
The Company is committed to continuous improvement in our approach to preventing modern slavery and human trafficking. The Company will regularly review and enhance our policies, procedures, and practices to ensure they remain effective. Its commitment extends to working closely with suppliers, partners, and stakeholders to uphold ethical standards throughout our operations and supply chains.
This statement has been approved by the Board of Directors of the Company and will be reviewed and updated annually to reflect our ongoing progress.
Andrew M. Spellman
CEO